[Press Release] We are very pleased to announce that our Director Elsa Kress attended the first in-person kick-off meeting of the Eurostars-funded REPRINT project!
The project is a consortium led by Asgard Therapeutics, together with Lund University, InSphero and ANTINEO. The project REPRogramming tumors INTo immune cells: a revolutionary gene therapy to treat cancer (REPRINT) will focus on providing definitive proof-of principle for the use of the novel cancer immunotherapy TrojanDC developed by Asgard for the treatment of hard-to-treat solid tumors.